Results 171 to 180 of about 13,452 (195)

Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease. [PDF]

Nat Commun
Telarovic I, Yong CSM, Kurz L, Vetrugno I, Reichl S, Fernandez AS, Cheng HW, Winkler R, Guckenberger M, Kipar A, Ludewig B, Pruschy M.   +11 more
europepmc   +1 more source

Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial. [PDF]

Nat Commun
Gong H, Tian S, Ding H, Tao L, Wang L, Wang J, Wang T, Yuan X, Heng Y, Zhang M, Shi Y, Xu C, Wu C, Wang S, Zhou L.   +14 more
europepmc   +1 more source

In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with ²²⁵Ac. [PDF]

EJNMMI Radiopharm Chem
Ondrák Fialová K, Ondrák L, Vlk M, Kozempel J, Nováková K, Nový Z, Hajduová K, Hajdúch M, Petřík M, Pruszynski M, Bruchertseifer F, Morgenstern A.   +11 more
europepmc   +1 more source

Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy. [PDF]

Adv Sci (Weinh)
Ming ZH, Zhang YQ, Song L, Chen M, Lin LL, He YY, Liu WL, Zhu YY, Zhang Y, Zhang GJ.   +9 more
europepmc   +1 more source

Assembling Au₈ clusters on surfaces of bifunctional nanoimmunomodulators for synergistically enhanced low dose radiotherapy of metastatic tumor. [PDF]

J Nanobiotechnology
Zhang R, Jia M, Lv H, Li M, Ding G, Cheng G, Li J.   +6 more
europepmc   +1 more source

Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Tojjari A, Yu J, Saeed A.
europepmc   +1 more source

Correction: Azari et al. The Efficacy of Ketamine for Acute and Chronic Pain in Patients with Cancer: A Systematic Review of Randomized Controlled Trials. Healthcare 2024, 12, 1560. [PDF]

Healthcare (Basel)
Azari L, Hemati H, Tavasolian R, Shahdab S, Tomlinson SM, Babilonia MB, Huang J, Tometich DB, Turner K, Anaraki KS, Jim HSL, Tabriz AA.   +11 more
europepmc   +1 more source

CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer. [PDF]

J Exp Clin Cancer Res
Li Z, Xue H, Li J, Zheng Z, Liu Z, Dong X, Wang H, Chen J, Xu S.   +8 more
europepmc   +1 more source

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. [PDF]

J Nucl Med
Mack KN, Samuels ZV, Carter LM, Viray TD, Mandleywala K, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy

Small Methods, 2023
In cancer treatment, traditional radiotherapy (RT) is routinely conducted in local tumors and limited by radioresistance, while recently emerged immunotherapy is confronted with low response rate, high cost, and cytokine release syndrome.
Teng Liu, Pei Pei, Wenhao Shen, Lin Hu, Kai Yang   +4 more
semanticscholar   +1 more source